Nautilus Biotechnology, Inc. (NAUT)
Data as of , from SEC Form 4 filings.
See up to 3 months of NAUT. The 7-day demo opens the 1M and 3M ranges and puts NAUT on your watchlist.
Start 7-day demoLatest NAUT insider trades
About Nautilus Biotechnology, Inc. (NAUT)
Nautilus Biotechnology, Inc. is an SEC registrant, filing under CIK 0001808805, classified as laboratory analytical instruments. We track it alongside the rest of the Health Care sector.
NAUT Form 4 activity by transaction type, last 90 days
No Form 4 activity for NAUT in the last 90 days.
NAUT insider transactions (Form 4)
1917 Form 4 filings on record, the earliest from Jun 23, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Matthew L. Posard - Director | Grant or award | Stock Option (Right to Buy) | 45,000 | $0.00 | - | |
| Farzad Nazem - Director | Grant or award | Stock Option (Right to Buy) | 45,000 | $0.00 | - | |
| Karen Akinsanya - Director | Grant or award | Stock Option (Right to Buy) | 45,000 | $0.00 | - | |
| Matthew S. McIlwain - Director | Grant or award | Stock Option (Right to Buy) | 45,000 | $0.00 | - | |
| Melissa B, Epperly - Director | Grant or award | Stock Option (Right to Buy) | 45,000 | $0.00 | - | |
| AH Equity Partners Bio II, L.L.C. | Open-market sale | Common Stock | 4,615,974 | $2.35 | $10.85M | |
| AH Equity Partners Bio II, L.L.C. | Open-market sale | Common Stock | 384,026 | $2.35 | $902K | |
| Anna Mowry - Officer | Grant or award | Stock Option (Right to Buy) | 160,000 | $0.00 | - | |
 Parag Mallick - Officer | Grant or award | Stock Option (Right to Buy) | 280,000 | $0.00 | - | |
 Sujal M. Patel - Officer | Grant or award | Stock Option (Right to Buy) | 650,000 | $0.00 | - | |
| Subramanian Sankar - Officer | Grant or award | Stock Option (Right to Buy) | 160,000 | $0.00 | - | |
 Gwen E. Weld - Officer | Grant or award | Stock Option (Right to Buy) | 160,000 | $0.00 | - | |
| Matthew B. Murphy - Officer | Grant or award | Stock Option (Right to Buy) | 160,000 | $0.00 | - | |
| Kentaro Suzuki - Officer | Grant or award | Stock Option (Right to Buy) | 160,000 | $0.00 | - | |
| Kentaro Suzuki - Officer | Open-market purchase | Common Stock | 4,000 | $1.49 | $6K | |
| Sujal M. Patel - Officer | Open-market purchase | Common Stock | 116,500 | $0.67 | $79K | |
| Sujal M. Patel - Officer | Open-market purchase | Common Stock | 83,500 | $0.68 | $57K | |
| Matthew B. Murphy - Officer | Open-market purchase | Common Stock | 20,000 | $0.64 | $13K | |
| Farzad Nazem - Director | Grant or award | Stock Option (Right to Buy) | 45,000 | $0.00 | - |
NAUT insider trading FAQ
What is the latest insider trade for NAUT?
Nautilus Biotechnology, Inc. (NAUT) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-22. The full record for NAUT runs to 17 Form 4 filings, the earliest from 2025-06-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NAUT stock?
No insider purchases of NAUT were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling NAUT stock?
No insider sales of NAUT were filed in the last 90 days. 2 sales are on record for this company.
Where can I see NAUT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NAUT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Matthew L. Posard view on EDGAR
- - Farzad Nazem view on EDGAR
- - Karen Akinsanya view on EDGAR
- - Matthew S. McIlwain view on EDGAR
- - Melissa B, Epperly view on EDGAR
- - AH Equity Partners Bio II, L.L.C. view on EDGAR
- - Anna Mowry view on EDGAR
- - Parag Mallick view on EDGAR
- - Sujal M. Patel view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where NAUT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NAUT with a 7-day demo
- NAUT on your watchlist
- Every NAUT Form 4 filing on record
- Up to 3 months of NAUT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
